Atara Biotherapeutics' GAAP loss for 9M 2021 was $246.792 million, up 9.5% from $225.313 million in the prior year. Revenue was $12.792 million versus $0 million. The company did not generate revenue a year earlier.
Atara Biotherapeutics' GAAP loss for 9M 2021 was $246.792 million, up 9.5% from $225.313 million in the prior year. Revenue was $12.792 million versus $0 million. The company did not generate revenue a year earlier. 
investors.atarabio.com
English (US) 